nodes	percent_of_prediction	percent_of_DWPC	metapath
Methadone—ABCB1—lung cancer	0.121	1	CbGaD
Methadone—CYP19A1—Paclitaxel—lung cancer	0.0361	0.059	CbGbCtD
Methadone—CYP3A5—Gefitinib—lung cancer	0.0217	0.0354	CbGbCtD
Methadone—CYP3A5—Teniposide—lung cancer	0.021	0.0344	CbGbCtD
Methadone—CYP2C19—Gefitinib—lung cancer	0.0175	0.0286	CbGbCtD
Methadone—CYP2C19—Teniposide—lung cancer	0.017	0.0277	CbGbCtD
Methadone—CYP3A7-CYP3A51P—Paclitaxel—lung cancer	0.0156	0.0256	CbGbCtD
Methadone—CYP3A7—Paclitaxel—lung cancer	0.0156	0.0256	CbGbCtD
Methadone—CYP3A7-CYP3A51P—Irinotecan—lung cancer	0.0154	0.0252	CbGbCtD
Methadone—CYP3A7—Irinotecan—lung cancer	0.0154	0.0252	CbGbCtD
Methadone—ABCB1—Topotecan—lung cancer	0.0154	0.0252	CbGbCtD
Methadone—CYP2B6—Irinotecan—lung cancer	0.0147	0.024	CbGbCtD
Methadone—CYP2C9—Gefitinib—lung cancer	0.0145	0.0238	CbGbCtD
Methadone—ABCB1—Gefitinib—lung cancer	0.0141	0.0231	CbGbCtD
Methadone—CYP2C9—Teniposide—lung cancer	0.0141	0.023	CbGbCtD
Methadone—CYP2D6—Gefitinib—lung cancer	0.0133	0.0217	CbGbCtD
Methadone—CYP3A5—Crizotinib—lung cancer	0.0133	0.0217	CbGbCtD
Methadone—CYP3A5—Erlotinib—lung cancer	0.0128	0.021	CbGbCtD
Methadone—CYP2C8—Erlotinib—lung cancer	0.0123	0.0201	CbGbCtD
Methadone—CYP2B6—Cisplatin—lung cancer	0.012	0.0196	CbGbCtD
Methadone—CYP3A5—Paclitaxel—lung cancer	0.0117	0.0192	CbGbCtD
Methadone—CYP3A5—Irinotecan—lung cancer	0.0116	0.0189	CbGbCtD
Methadone—CYP3A7—Docetaxel—lung cancer	0.0113	0.0185	CbGbCtD
Methadone—CYP3A7-CYP3A51P—Docetaxel—lung cancer	0.0113	0.0185	CbGbCtD
Methadone—CYP2C8—Paclitaxel—lung cancer	0.0113	0.0184	CbGbCtD
Methadone—ABCB1—Vinorelbine—lung cancer	0.0109	0.0178	CbGbCtD
Methadone—CYP2D6—Vinorelbine—lung cancer	0.0102	0.0167	CbGbCtD
Methadone—CYP1A2—Erlotinib—lung cancer	0.00954	0.0156	CbGbCtD
Methadone—CYP3A5—Etoposide—lung cancer	0.00927	0.0152	CbGbCtD
Methadone—CYP3A4—Topotecan—lung cancer	0.00924	0.0151	CbGbCtD
Methadone—CYP2C8—Etoposide—lung cancer	0.00891	0.0146	CbGbCtD
Methadone—ABCB1—Crizotinib—lung cancer	0.00865	0.0141	CbGbCtD
Methadone—CYP3A5—Docetaxel—lung cancer	0.00848	0.0139	CbGbCtD
Methadone—CYP3A4—Gefitinib—lung cancer	0.00845	0.0138	CbGbCtD
Methadone—ABCB1—Gemcitabine—lung cancer	0.00845	0.0138	CbGbCtD
Methadone—ABCB1—Erlotinib—lung cancer	0.00834	0.0136	CbGbCtD
Methadone—CYP3A4—Teniposide—lung cancer	0.00819	0.0134	CbGbCtD
Methadone—CYP2B6—Doxorubicin—lung cancer	0.00803	0.0131	CbGbCtD
Methadone—CYP2C9—Paclitaxel—lung cancer	0.00787	0.0129	CbGbCtD
Methadone—CYP2D6—Erlotinib—lung cancer	0.00786	0.0129	CbGbCtD
Methadone—ABCB1—Paclitaxel—lung cancer	0.00763	0.0125	CbGbCtD
Methadone—ABCB1—Irinotecan—lung cancer	0.00753	0.0123	CbGbCtD
Methadone—CYP1A2—Etoposide—lung cancer	0.0069	0.0113	CbGbCtD
Methadone—ABCB1—Vinblastine—lung cancer	0.0067	0.011	CbGbCtD
Methadone—CYP3A4—Vinorelbine—lung cancer	0.00651	0.0106	CbGbCtD
Methadone—CYP2C9—Cisplatin—lung cancer	0.00633	0.0103	CbGbCtD
Methadone—CYP2D6—Vinblastine—lung cancer	0.00631	0.0103	CbGbCtD
Methadone—ABCB1—Cisplatin—lung cancer	0.00614	0.01	CbGbCtD
Methadone—ABCB1—Etoposide—lung cancer	0.00603	0.00987	CbGbCtD
Methadone—ABCB1—Docetaxel—lung cancer	0.00552	0.00903	CbGbCtD
Methadone—CYP3A4—Crizotinib—lung cancer	0.00518	0.00847	CbGbCtD
Methadone—CYP3A4—Erlotinib—lung cancer	0.005	0.00817	CbGbCtD
Methadone—CYP3A4—Paclitaxel—lung cancer	0.00457	0.00748	CbGbCtD
Methadone—CYP3A4—Irinotecan—lung cancer	0.00451	0.00738	CbGbCtD
Methadone—ABCB1—Doxorubicin—lung cancer	0.00411	0.00673	CbGbCtD
Methadone—CYP3A4—Vinblastine—lung cancer	0.00401	0.00656	CbGbCtD
Methadone—ABCB1—Methotrexate—lung cancer	0.00399	0.00652	CbGbCtD
Methadone—CYP2D6—Doxorubicin—lung cancer	0.00388	0.00634	CbGbCtD
Methadone—CYP3A4—Etoposide—lung cancer	0.00361	0.00591	CbGbCtD
Methadone—CYP3A4—Docetaxel—lung cancer	0.00331	0.00541	CbGbCtD
Methadone—CYP3A4—Doxorubicin—lung cancer	0.00247	0.00403	CbGbCtD
Methadone—Levomethadyl Acetate—CHRNB4—lung cancer	0.000745	0.194	CrCbGaD
Methadone—Loperamide—POMC—lung cancer	0.000561	0.146	CrCbGaD
Methadone—Levomethadyl Acetate—CHRNA3—lung cancer	0.000517	0.134	CrCbGaD
Methadone—Clotrimazole—ABCC3—lung cancer	0.000402	0.104	CrCbGaD
Methadone—Clotrimazole—CYP2A6—lung cancer	0.000218	0.0567	CrCbGaD
Methadone—Oxaprozin—PTGS2—lung cancer	0.000161	0.0419	CrCbGaD
Methadone—Clotrimazole—CYP2E1—lung cancer	0.000155	0.0402	CrCbGaD
Methadone—Loss of consciousness—Etoposide—lung cancer	0.000153	0.00104	CcSEcCtD
Methadone—Rash—Topotecan—lung cancer	0.000152	0.00104	CcSEcCtD
Methadone—Hypersensitivity—Vinorelbine—lung cancer	0.000152	0.00104	CcSEcCtD
Methadone—Dermatitis—Topotecan—lung cancer	0.000152	0.00104	CcSEcCtD
Methadone—Vomiting—Erlotinib—lung cancer	0.000152	0.00103	CcSEcCtD
Methadone—Somnolence—Irinotecan—lung cancer	0.000152	0.00103	CcSEcCtD
Methadone—Thrombocytopenia—Cisplatin—lung cancer	0.000152	0.00103	CcSEcCtD
Methadone—Headache—Topotecan—lung cancer	0.000151	0.00103	CcSEcCtD
Methadone—Tachycardia—Cisplatin—lung cancer	0.000151	0.00103	CcSEcCtD
Methadone—Rash—Erlotinib—lung cancer	0.000151	0.00103	CcSEcCtD
Methadone—Dermatitis—Erlotinib—lung cancer	0.000151	0.00102	CcSEcCtD
Methadone—Palpitations—Paclitaxel—lung cancer	0.000151	0.00102	CcSEcCtD
Methadone—Convulsion—Etoposide—lung cancer	0.000151	0.00102	CcSEcCtD
Methadone—Insomnia—Gemcitabine—lung cancer	0.00015	0.00102	CcSEcCtD
Methadone—Headache—Erlotinib—lung cancer	0.00015	0.00102	CcSEcCtD
Methadone—Loss of consciousness—Paclitaxel—lung cancer	0.00015	0.00102	CcSEcCtD
Methadone—Hyperhidrosis—Cisplatin—lung cancer	0.00015	0.00102	CcSEcCtD
Methadone—Chills—Docetaxel—lung cancer	0.000149	0.00101	CcSEcCtD
Methadone—Asthenia—Vinorelbine—lung cancer	0.000148	0.00101	CcSEcCtD
Methadone—Decreased appetite—Irinotecan—lung cancer	0.000148	0.00101	CcSEcCtD
Methadone—Arrhythmia—Docetaxel—lung cancer	0.000148	0.00101	CcSEcCtD
Methadone—Nausea—Vinblastine—lung cancer	0.000148	0.001	CcSEcCtD
Methadone—Somnolence—Gemcitabine—lung cancer	0.000148	0.001	CcSEcCtD
Methadone—Convulsion—Paclitaxel—lung cancer	0.000148	0.001	CcSEcCtD
Methadone—Anorexia—Cisplatin—lung cancer	0.000148	0.001	CcSEcCtD
Methadone—Pruritus—Vinorelbine—lung cancer	0.000146	0.000995	CcSEcCtD
Methadone—Pain—Irinotecan—lung cancer	0.000146	0.000992	CcSEcCtD
Methadone—Constipation—Irinotecan—lung cancer	0.000146	0.000992	CcSEcCtD
Methadone—Hypotension—Cisplatin—lung cancer	0.000145	0.000984	CcSEcCtD
Methadone—Anxiety—Paclitaxel—lung cancer	0.000145	0.000983	CcSEcCtD
Methadone—Erythema—Docetaxel—lung cancer	0.000144	0.000982	CcSEcCtD
Methadone—Decreased appetite—Gemcitabine—lung cancer	0.000144	0.000982	CcSEcCtD
Methadone—Nausea—Topotecan—lung cancer	0.000144	0.000976	CcSEcCtD
Methadone—Confusional state—Etoposide—lung cancer	0.000143	0.000972	CcSEcCtD
Methadone—Cardiac arrest—Doxorubicin—lung cancer	0.000142	0.000968	CcSEcCtD
Methadone—Constipation—Gemcitabine—lung cancer	0.000142	0.000966	CcSEcCtD
Methadone—Pain—Gemcitabine—lung cancer	0.000142	0.000966	CcSEcCtD
Methadone—Nausea—Erlotinib—lung cancer	0.000142	0.000966	CcSEcCtD
Methadone—Dry mouth—Paclitaxel—lung cancer	0.000142	0.000965	CcSEcCtD
Methadone—Anaphylactic shock—Etoposide—lung cancer	0.000142	0.000964	CcSEcCtD
Methadone—Diarrhoea—Vinorelbine—lung cancer	0.000142	0.000962	CcSEcCtD
Methadone—Feeling abnormal—Irinotecan—lung cancer	0.000141	0.000955	CcSEcCtD
Methadone—Confusional state—Paclitaxel—lung cancer	0.00014	0.000953	CcSEcCtD
Methadone—Gastrointestinal pain—Irinotecan—lung cancer	0.000139	0.000948	CcSEcCtD
Methadone—Anaphylactic shock—Paclitaxel—lung cancer	0.000139	0.000946	CcSEcCtD
Methadone—Oedema—Paclitaxel—lung cancer	0.000139	0.000946	CcSEcCtD
Methadone—Thrombocytopenia—Etoposide—lung cancer	0.000139	0.000944	CcSEcCtD
Methadone—Muscle spasms—Docetaxel—lung cancer	0.000139	0.000944	CcSEcCtD
Methadone—Tachycardia—Etoposide—lung cancer	0.000138	0.000941	CcSEcCtD
Methadone—Hyperhidrosis—Etoposide—lung cancer	0.000137	0.000932	CcSEcCtD
Methadone—Feeling abnormal—Gemcitabine—lung cancer	0.000137	0.000931	CcSEcCtD
Methadone—Shock—Paclitaxel—lung cancer	0.000137	0.00093	CcSEcCtD
Methadone—Dizziness—Vinorelbine—lung cancer	0.000137	0.00093	CcSEcCtD
Methadone—Orthostatic hypotension—Doxorubicin—lung cancer	0.000137	0.00093	CcSEcCtD
Methadone—Hypokalaemia—Doxorubicin—lung cancer	0.000136	0.000926	CcSEcCtD
Methadone—Thrombocytopenia—Paclitaxel—lung cancer	0.000136	0.000926	CcSEcCtD
Methadone—Tachycardia—Paclitaxel—lung cancer	0.000136	0.000923	CcSEcCtD
Methadone—Anorexia—Etoposide—lung cancer	0.000135	0.000919	CcSEcCtD
Methadone—Body temperature increased—Irinotecan—lung cancer	0.000135	0.000917	CcSEcCtD
Methadone—Abdominal pain—Irinotecan—lung cancer	0.000135	0.000917	CcSEcCtD
Methadone—Decreased appetite—Cisplatin—lung cancer	0.000135	0.000915	CcSEcCtD
Methadone—Hyperhidrosis—Paclitaxel—lung cancer	0.000134	0.000914	CcSEcCtD
Methadone—Nasopharyngitis—Doxorubicin—lung cancer	0.000134	0.00091	CcSEcCtD
Methadone—Drowsiness—Methotrexate—lung cancer	0.000133	0.000906	CcSEcCtD
Methadone—Anorexia—Paclitaxel—lung cancer	0.000133	0.000901	CcSEcCtD
Methadone—Hypotension—Etoposide—lung cancer	0.000133	0.000901	CcSEcCtD
Methadone—Pain—Cisplatin—lung cancer	0.000132	0.0009	CcSEcCtD
Methadone—Vomiting—Vinorelbine—lung cancer	0.000132	0.000894	CcSEcCtD
Methadone—Body temperature increased—Gemcitabine—lung cancer	0.000131	0.000893	CcSEcCtD
Methadone—Rash—Vinorelbine—lung cancer	0.00013	0.000886	CcSEcCtD
Methadone—Dermatitis—Vinorelbine—lung cancer	0.00013	0.000886	CcSEcCtD
Methadone—Hypotension—Paclitaxel—lung cancer	0.00013	0.000884	CcSEcCtD
Methadone—Headache—Vinorelbine—lung cancer	0.00013	0.000881	CcSEcCtD
Methadone—Syncope—Docetaxel—lung cancer	0.00013	0.000881	CcSEcCtD
Methadone—Tamoxifen—CYP2A6—lung cancer	0.000129	0.0335	CrCbGaD
Methadone—Sweating—Methotrexate—lung cancer	0.000128	0.000868	CcSEcCtD
Methadone—Palpitations—Docetaxel—lung cancer	0.000128	0.000868	CcSEcCtD
Methadone—Feeling abnormal—Cisplatin—lung cancer	0.000128	0.000868	CcSEcCtD
Methadone—Loss of consciousness—Docetaxel—lung cancer	0.000127	0.000863	CcSEcCtD
Methadone—Somnolence—Etoposide—lung cancer	0.000126	0.000857	CcSEcCtD
Methadone—Insomnia—Paclitaxel—lung cancer	0.000126	0.000855	CcSEcCtD
Methadone—Hypersensitivity—Irinotecan—lung cancer	0.000126	0.000854	CcSEcCtD
Methadone—Convulsion—Docetaxel—lung cancer	0.000125	0.000851	CcSEcCtD
Methadone—Somnolence—Paclitaxel—lung cancer	0.000124	0.000841	CcSEcCtD
Methadone—Decreased appetite—Etoposide—lung cancer	0.000123	0.000838	CcSEcCtD
Methadone—Nausea—Vinorelbine—lung cancer	0.000123	0.000835	CcSEcCtD
Methadone—Body temperature increased—Cisplatin—lung cancer	0.000122	0.000832	CcSEcCtD
Methadone—Asthenia—Irinotecan—lung cancer	0.000122	0.000832	CcSEcCtD
Methadone—Pain—Etoposide—lung cancer	0.000121	0.000825	CcSEcCtD
Methadone—Constipation—Etoposide—lung cancer	0.000121	0.000825	CcSEcCtD
Methadone—Decreased appetite—Paclitaxel—lung cancer	0.000121	0.000822	CcSEcCtD
Methadone—Dry mouth—Docetaxel—lung cancer	0.00012	0.000818	CcSEcCtD
Methadone—Asthenia—Gemcitabine—lung cancer	0.000119	0.00081	CcSEcCtD
Methadone—Constipation—Paclitaxel—lung cancer	0.000119	0.000809	CcSEcCtD
Methadone—Pain—Paclitaxel—lung cancer	0.000119	0.000809	CcSEcCtD
Methadone—Confusional state—Docetaxel—lung cancer	0.000119	0.000808	CcSEcCtD
Methadone—Oedema—Docetaxel—lung cancer	0.000118	0.000802	CcSEcCtD
Methadone—Anaphylactic shock—Docetaxel—lung cancer	0.000118	0.000802	CcSEcCtD
Methadone—Weight increased—Doxorubicin—lung cancer	0.000118	0.000801	CcSEcCtD
Methadone—Pruritus—Gemcitabine—lung cancer	0.000118	0.000799	CcSEcCtD
Methadone—Weight decreased—Doxorubicin—lung cancer	0.000117	0.000796	CcSEcCtD
Methadone—Feeling abnormal—Etoposide—lung cancer	0.000117	0.000795	CcSEcCtD
Methadone—Diarrhoea—Irinotecan—lung cancer	0.000117	0.000793	CcSEcCtD
Methadone—Gastrointestinal pain—Etoposide—lung cancer	0.000116	0.000789	CcSEcCtD
Methadone—Shock—Docetaxel—lung cancer	0.000116	0.000789	CcSEcCtD
Methadone—Thrombocytopenia—Docetaxel—lung cancer	0.000115	0.000785	CcSEcCtD
Methadone—Tamoxifen—ABCG2—lung cancer	0.000115	0.03	CrCbGaD
Methadone—Drowsiness—Doxorubicin—lung cancer	0.000115	0.000784	CcSEcCtD
Methadone—Visual impairment—Methotrexate—lung cancer	0.000115	0.000784	CcSEcCtD
Methadone—Tachycardia—Docetaxel—lung cancer	0.000115	0.000782	CcSEcCtD
Methadone—Feeling abnormal—Paclitaxel—lung cancer	0.000115	0.000779	CcSEcCtD
Methadone—Hypersensitivity—Cisplatin—lung cancer	0.000114	0.000776	CcSEcCtD
Methadone—Gastrointestinal pain—Paclitaxel—lung cancer	0.000114	0.000773	CcSEcCtD
Methadone—Diarrhoea—Gemcitabine—lung cancer	0.000114	0.000773	CcSEcCtD
Methadone—Dizziness—Irinotecan—lung cancer	0.000113	0.000767	CcSEcCtD
Methadone—Urticaria—Etoposide—lung cancer	0.000113	0.000766	CcSEcCtD
Methadone—Anorexia—Docetaxel—lung cancer	0.000112	0.000764	CcSEcCtD
Methadone—Body temperature increased—Etoposide—lung cancer	0.000112	0.000762	CcSEcCtD
Methadone—Abdominal pain—Etoposide—lung cancer	0.000112	0.000762	CcSEcCtD
Methadone—Asthenia—Cisplatin—lung cancer	0.000111	0.000755	CcSEcCtD
Methadone—Sweating—Doxorubicin—lung cancer	0.000111	0.000752	CcSEcCtD
Methadone—Urticaria—Paclitaxel—lung cancer	0.000111	0.000751	CcSEcCtD
Methadone—Hypotension—Docetaxel—lung cancer	0.00011	0.000749	CcSEcCtD
Methadone—Body temperature increased—Paclitaxel—lung cancer	0.00011	0.000748	CcSEcCtD
Methadone—Abdominal pain—Paclitaxel—lung cancer	0.00011	0.000748	CcSEcCtD
Methadone—Vomiting—Irinotecan—lung cancer	0.000108	0.000737	CcSEcCtD
Methadone—Rash—Irinotecan—lung cancer	0.000108	0.000731	CcSEcCtD
Methadone—Dermatitis—Irinotecan—lung cancer	0.000107	0.00073	CcSEcCtD
Methadone—Chills—Methotrexate—lung cancer	0.000107	0.00073	CcSEcCtD
Methadone—Headache—Irinotecan—lung cancer	0.000107	0.000726	CcSEcCtD
Methadone—Insomnia—Docetaxel—lung cancer	0.000107	0.000725	CcSEcCtD
Methadone—Phenylbutazone—PTGS2—lung cancer	0.000107	0.0277	CrCbGaD
Methadone—Diarrhoea—Cisplatin—lung cancer	0.000106	0.00072	CcSEcCtD
Methadone—Vomiting—Gemcitabine—lung cancer	0.000106	0.000718	CcSEcCtD
Methadone—Bradycardia—Doxorubicin—lung cancer	0.000105	0.000717	CcSEcCtD
Methadone—Fexofenadine—ABCB1—lung cancer	0.000105	0.0273	CrCbGaD
Methadone—Somnolence—Docetaxel—lung cancer	0.000105	0.000713	CcSEcCtD
Methadone—Rash—Gemcitabine—lung cancer	0.000105	0.000712	CcSEcCtD
Methadone—Dermatitis—Gemcitabine—lung cancer	0.000105	0.000711	CcSEcCtD
Methadone—Hypersensitivity—Etoposide—lung cancer	0.000105	0.000711	CcSEcCtD
Methadone—Erythema—Methotrexate—lung cancer	0.000104	0.000708	CcSEcCtD
Methadone—Headache—Gemcitabine—lung cancer	0.000104	0.000708	CcSEcCtD
Methadone—Decreased appetite—Docetaxel—lung cancer	0.000103	0.000697	CcSEcCtD
Methadone—Hypersensitivity—Paclitaxel—lung cancer	0.000103	0.000697	CcSEcCtD
Methadone—Asthenia—Etoposide—lung cancer	0.000102	0.000692	CcSEcCtD
Methadone—Nausea—Irinotecan—lung cancer	0.000101	0.000689	CcSEcCtD
Methadone—Constipation—Docetaxel—lung cancer	0.000101	0.000685	CcSEcCtD
Methadone—Pain—Docetaxel—lung cancer	0.000101	0.000685	CcSEcCtD
Methadone—Pruritus—Etoposide—lung cancer	0.0001	0.000682	CcSEcCtD
Methadone—Visual impairment—Doxorubicin—lung cancer	9.98e-05	0.000679	CcSEcCtD
Methadone—Asthenia—Paclitaxel—lung cancer	9.98e-05	0.000678	CcSEcCtD
Methadone—Nausea—Gemcitabine—lung cancer	9.87e-05	0.000671	CcSEcCtD
Methadone—Vomiting—Cisplatin—lung cancer	9.85e-05	0.000669	CcSEcCtD
Methadone—Pruritus—Paclitaxel—lung cancer	9.84e-05	0.000669	CcSEcCtD
Methadone—Rash—Cisplatin—lung cancer	9.77e-05	0.000664	CcSEcCtD
Methadone—Dermatitis—Cisplatin—lung cancer	9.76e-05	0.000663	CcSEcCtD
Methadone—Feeling abnormal—Docetaxel—lung cancer	9.72e-05	0.00066	CcSEcCtD
Methadone—Diarrhoea—Etoposide—lung cancer	9.71e-05	0.00066	CcSEcCtD
Methadone—Gastrointestinal pain—Docetaxel—lung cancer	9.64e-05	0.000655	CcSEcCtD
Methadone—Flushing—Doxorubicin—lung cancer	9.61e-05	0.000653	CcSEcCtD
Methadone—Diarrhoea—Paclitaxel—lung cancer	9.52e-05	0.000647	CcSEcCtD
Methadone—Dizziness—Etoposide—lung cancer	9.38e-05	0.000638	CcSEcCtD
Methadone—Vertigo—Methotrexate—lung cancer	9.36e-05	0.000636	CcSEcCtD
Methadone—Abdominal pain—Docetaxel—lung cancer	9.32e-05	0.000634	CcSEcCtD
Methadone—Body temperature increased—Docetaxel—lung cancer	9.32e-05	0.000634	CcSEcCtD
Methadone—Chills—Doxorubicin—lung cancer	9.29e-05	0.000632	CcSEcCtD
Methadone—Arrhythmia—Doxorubicin—lung cancer	9.25e-05	0.000629	CcSEcCtD
Methadone—Dizziness—Paclitaxel—lung cancer	9.2e-05	0.000625	CcSEcCtD
Methadone—Nausea—Cisplatin—lung cancer	9.2e-05	0.000625	CcSEcCtD
Methadone—Tamoxifen—CYP2E1—lung cancer	9.16e-05	0.0238	CrCbGaD
Methadone—Tamoxifen—CYP1A1—lung cancer	9.04e-05	0.0235	CrCbGaD
Methadone—Convulsion—Methotrexate—lung cancer	9.02e-05	0.000613	CcSEcCtD
Methadone—Vomiting—Etoposide—lung cancer	9.02e-05	0.000613	CcSEcCtD
Methadone—Erythema—Doxorubicin—lung cancer	9.02e-05	0.000613	CcSEcCtD
Methadone—Rash—Etoposide—lung cancer	8.95e-05	0.000608	CcSEcCtD
Methadone—Dermatitis—Etoposide—lung cancer	8.94e-05	0.000608	CcSEcCtD
Methadone—Orphenadrine—CYP2E1—lung cancer	8.9e-05	0.0231	CrCbGaD
Methadone—Headache—Etoposide—lung cancer	8.89e-05	0.000604	CcSEcCtD
Methadone—Vomiting—Paclitaxel—lung cancer	8.85e-05	0.000601	CcSEcCtD
Methadone—Rash—Paclitaxel—lung cancer	8.77e-05	0.000596	CcSEcCtD
Methadone—Dermatitis—Paclitaxel—lung cancer	8.76e-05	0.000596	CcSEcCtD
Methadone—Headache—Paclitaxel—lung cancer	8.72e-05	0.000592	CcSEcCtD
Methadone—Hypersensitivity—Docetaxel—lung cancer	8.69e-05	0.000591	CcSEcCtD
Methadone—Muscle spasms—Doxorubicin—lung cancer	8.67e-05	0.000589	CcSEcCtD
Methadone—Confusional state—Methotrexate—lung cancer	8.57e-05	0.000582	CcSEcCtD
Methadone—Anaphylactic shock—Methotrexate—lung cancer	8.5e-05	0.000578	CcSEcCtD
Methadone—Asthenia—Docetaxel—lung cancer	8.46e-05	0.000575	CcSEcCtD
Methadone—Nausea—Etoposide—lung cancer	8.43e-05	0.000573	CcSEcCtD
Methadone—Pruritus—Docetaxel—lung cancer	8.34e-05	0.000567	CcSEcCtD
Methadone—Thrombocytopenia—Methotrexate—lung cancer	8.32e-05	0.000566	CcSEcCtD
Methadone—Agitation—Doxorubicin—lung cancer	8.29e-05	0.000563	CcSEcCtD
Methadone—Nausea—Paclitaxel—lung cancer	8.26e-05	0.000562	CcSEcCtD
Methadone—Hyperhidrosis—Methotrexate—lung cancer	8.22e-05	0.000558	CcSEcCtD
Methadone—Clotrimazole—ABCB1—lung cancer	8.13e-05	0.0211	CrCbGaD
Methadone—Vertigo—Doxorubicin—lung cancer	8.1e-05	0.000551	CcSEcCtD
Methadone—Anorexia—Methotrexate—lung cancer	8.1e-05	0.000551	CcSEcCtD
Methadone—Syncope—Doxorubicin—lung cancer	8.09e-05	0.00055	CcSEcCtD
Methadone—Diarrhoea—Docetaxel—lung cancer	8.07e-05	0.000548	CcSEcCtD
Methadone—Palpitations—Doxorubicin—lung cancer	7.97e-05	0.000542	CcSEcCtD
Methadone—Hypotension—Methotrexate—lung cancer	7.94e-05	0.00054	CcSEcCtD
Methadone—Loss of consciousness—Doxorubicin—lung cancer	7.93e-05	0.000539	CcSEcCtD
Methadone—Convulsion—Doxorubicin—lung cancer	7.81e-05	0.000531	CcSEcCtD
Methadone—Dizziness—Docetaxel—lung cancer	7.8e-05	0.00053	CcSEcCtD
Methadone—Insomnia—Methotrexate—lung cancer	7.69e-05	0.000522	CcSEcCtD
Methadone—Anxiety—Doxorubicin—lung cancer	7.65e-05	0.00052	CcSEcCtD
Methadone—Somnolence—Methotrexate—lung cancer	7.56e-05	0.000514	CcSEcCtD
Methadone—Dry mouth—Doxorubicin—lung cancer	7.51e-05	0.00051	CcSEcCtD
Methadone—Vomiting—Docetaxel—lung cancer	7.5e-05	0.00051	CcSEcCtD
Methadone—Rash—Docetaxel—lung cancer	7.44e-05	0.000505	CcSEcCtD
Methadone—Dermatitis—Docetaxel—lung cancer	7.43e-05	0.000505	CcSEcCtD
Methadone—Confusional state—Doxorubicin—lung cancer	7.42e-05	0.000504	CcSEcCtD
Methadone—Decreased appetite—Methotrexate—lung cancer	7.39e-05	0.000502	CcSEcCtD
Methadone—Headache—Docetaxel—lung cancer	7.39e-05	0.000502	CcSEcCtD
Methadone—Anaphylactic shock—Doxorubicin—lung cancer	7.36e-05	0.0005	CcSEcCtD
Methadone—Oedema—Doxorubicin—lung cancer	7.36e-05	0.0005	CcSEcCtD
Methadone—Pain—Methotrexate—lung cancer	7.27e-05	0.000494	CcSEcCtD
Methadone—Shock—Doxorubicin—lung cancer	7.24e-05	0.000492	CcSEcCtD
Methadone—Thrombocytopenia—Doxorubicin—lung cancer	7.21e-05	0.00049	CcSEcCtD
Methadone—Tachycardia—Doxorubicin—lung cancer	7.18e-05	0.000488	CcSEcCtD
Methadone—Hyperhidrosis—Doxorubicin—lung cancer	7.11e-05	0.000484	CcSEcCtD
Methadone—Anorexia—Doxorubicin—lung cancer	7.02e-05	0.000477	CcSEcCtD
Methadone—Nausea—Docetaxel—lung cancer	7e-05	0.000476	CcSEcCtD
Methadone—Feeling abnormal—Methotrexate—lung cancer	7e-05	0.000476	CcSEcCtD
Methadone—Gastrointestinal pain—Methotrexate—lung cancer	6.95e-05	0.000472	CcSEcCtD
Methadone—Fentanyl—ABCB1—lung cancer	6.95e-05	0.018	CrCbGaD
Methadone—Hypotension—Doxorubicin—lung cancer	6.88e-05	0.000467	CcSEcCtD
Methadone—Urticaria—Methotrexate—lung cancer	6.75e-05	0.000459	CcSEcCtD
Methadone—Abdominal pain—Methotrexate—lung cancer	6.72e-05	0.000457	CcSEcCtD
Methadone—Body temperature increased—Methotrexate—lung cancer	6.72e-05	0.000457	CcSEcCtD
Methadone—Loperamide—ABCB1—lung cancer	6.69e-05	0.0174	CrCbGaD
Methadone—Insomnia—Doxorubicin—lung cancer	6.66e-05	0.000452	CcSEcCtD
Methadone—Somnolence—Doxorubicin—lung cancer	6.54e-05	0.000445	CcSEcCtD
Methadone—Decreased appetite—Doxorubicin—lung cancer	6.4e-05	0.000435	CcSEcCtD
Methadone—Pain—Doxorubicin—lung cancer	6.29e-05	0.000428	CcSEcCtD
Methadone—Constipation—Doxorubicin—lung cancer	6.29e-05	0.000428	CcSEcCtD
Methadone—Hypersensitivity—Methotrexate—lung cancer	6.26e-05	0.000426	CcSEcCtD
Methadone—Asthenia—Methotrexate—lung cancer	6.1e-05	0.000414	CcSEcCtD
Methadone—Feeling abnormal—Doxorubicin—lung cancer	6.06e-05	0.000412	CcSEcCtD
Methadone—Gastrointestinal pain—Doxorubicin—lung cancer	6.02e-05	0.000409	CcSEcCtD
Methadone—Pruritus—Methotrexate—lung cancer	6.01e-05	0.000409	CcSEcCtD
Methadone—Urticaria—Doxorubicin—lung cancer	5.85e-05	0.000397	CcSEcCtD
Methadone—Abdominal pain—Doxorubicin—lung cancer	5.82e-05	0.000395	CcSEcCtD
Methadone—Body temperature increased—Doxorubicin—lung cancer	5.82e-05	0.000395	CcSEcCtD
Methadone—Diarrhoea—Methotrexate—lung cancer	5.82e-05	0.000395	CcSEcCtD
Methadone—Dizziness—Methotrexate—lung cancer	5.62e-05	0.000382	CcSEcCtD
Methadone—Hypersensitivity—Doxorubicin—lung cancer	5.42e-05	0.000369	CcSEcCtD
Methadone—Vomiting—Methotrexate—lung cancer	5.4e-05	0.000367	CcSEcCtD
Methadone—Rash—Methotrexate—lung cancer	5.36e-05	0.000364	CcSEcCtD
Methadone—Dermatitis—Methotrexate—lung cancer	5.35e-05	0.000364	CcSEcCtD
Methadone—Headache—Methotrexate—lung cancer	5.32e-05	0.000362	CcSEcCtD
Methadone—Asthenia—Doxorubicin—lung cancer	5.28e-05	0.000359	CcSEcCtD
Methadone—Pruritus—Doxorubicin—lung cancer	5.21e-05	0.000354	CcSEcCtD
Methadone—Nausea—Methotrexate—lung cancer	5.05e-05	0.000343	CcSEcCtD
Methadone—Diarrhoea—Doxorubicin—lung cancer	5.04e-05	0.000342	CcSEcCtD
Methadone—Trimipramine—ABCB1—lung cancer	5.02e-05	0.013	CrCbGaD
Methadone—Dizziness—Doxorubicin—lung cancer	4.87e-05	0.000331	CcSEcCtD
Methadone—Promethazine—ABCB1—lung cancer	4.84e-05	0.0126	CrCbGaD
Methadone—Tamoxifen—ABCB1—lung cancer	4.8e-05	0.0125	CrCbGaD
Methadone—Vomiting—Doxorubicin—lung cancer	4.68e-05	0.000318	CcSEcCtD
Methadone—Rash—Doxorubicin—lung cancer	4.64e-05	0.000315	CcSEcCtD
Methadone—Dermatitis—Doxorubicin—lung cancer	4.64e-05	0.000315	CcSEcCtD
Methadone—Headache—Doxorubicin—lung cancer	4.61e-05	0.000313	CcSEcCtD
Methadone—Nausea—Doxorubicin—lung cancer	4.37e-05	0.000297	CcSEcCtD
Methadone—CYP2C8—Metabolism—ERCC2—lung cancer	4.52e-06	3.9e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism of lipids and lipoproteins—EP300—lung cancer	4.52e-06	3.89e-05	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—APOA1—lung cancer	4.52e-06	3.89e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—ALDOA—lung cancer	4.51e-06	3.89e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—CCND1—lung cancer	4.5e-06	3.88e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—JUN—lung cancer	4.49e-06	3.87e-05	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—VEGFA—lung cancer	4.48e-06	3.86e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—CAT—lung cancer	4.44e-06	3.82e-05	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—STAT3—lung cancer	4.43e-06	3.82e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—ABCB1—lung cancer	4.42e-06	3.81e-05	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—NRAS—lung cancer	4.42e-06	3.81e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—CYP2E1—lung cancer	4.42e-06	3.8e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling by GPCR—PIK3CA—lung cancer	4.39e-06	3.78e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—NCOA3—lung cancer	4.38e-06	3.77e-05	CbGpPWpGaD
Methadone—CYP3A7—Metabolism—PIK3CB—lung cancer	4.37e-06	3.77e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—MMP9—lung cancer	4.37e-06	3.77e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—MDM2—lung cancer	4.37e-06	3.76e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—NQO1—lung cancer	4.37e-06	3.76e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—CDKN1A—lung cancer	4.36e-06	3.75e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—RAF1—lung cancer	4.35e-06	3.75e-05	CbGpPWpGaD
Methadone—CYP19A1—Metabolism—PTEN—lung cancer	4.35e-06	3.75e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—PTEN—lung cancer	4.35e-06	3.74e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—TYMS—lung cancer	4.35e-06	3.74e-05	CbGpPWpGaD
Methadone—CYP3A7—Metabolism—PTGS2—lung cancer	4.33e-06	3.73e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—lung cancer	4.32e-06	3.72e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—ERBB2—lung cancer	4.31e-06	3.71e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—GSTP1—lung cancer	4.3e-06	3.7e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—GSTM1—lung cancer	4.3e-06	3.7e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	4.28e-06	3.68e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—ADCY1—lung cancer	4.26e-06	3.67e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—ABCG2—lung cancer	4.26e-06	3.67e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—GSTP1—lung cancer	4.26e-06	3.67e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—PIK3CB—lung cancer	4.25e-06	3.66e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—MTOR—lung cancer	4.25e-06	3.66e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—TYMS—lung cancer	4.24e-06	3.65e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling by GPCR—AKT1—lung cancer	4.24e-06	3.65e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	4.24e-06	3.65e-05	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—MAPK3—lung cancer	4.24e-06	3.65e-05	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—PIK3CG—lung cancer	4.22e-06	3.63e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—GSTM1—lung cancer	4.19e-06	3.61e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—CAT—lung cancer	4.18e-06	3.6e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—HPGDS—lung cancer	4.18e-06	3.6e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—ENO2—lung cancer	4.18e-06	3.6e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—PPP2R1B—lung cancer	4.15e-06	3.58e-05	CbGpPWpGaD
Methadone—CYP19A1—Metabolism—EP300—lung cancer	4.15e-06	3.57e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—CAT—lung cancer	4.15e-06	3.57e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—EP300—lung cancer	4.15e-06	3.57e-05	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—PIK3CG—lung cancer	4.13e-06	3.55e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism of lipids and lipoproteins—EP300—lung cancer	4.12e-06	3.55e-05	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—MYC—lung cancer	4.12e-06	3.55e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—CXCL8—lung cancer	4.09e-06	3.52e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—CYP1A1—lung cancer	4.07e-06	3.51e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—ABCB1—lung cancer	4.07e-06	3.5e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling by GPCR—HRAS—lung cancer	4.06e-06	3.5e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—GSTT1—lung cancer	4.06e-06	3.49e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—ERCC2—lung cancer	4.04e-06	3.48e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—ABCB1—lung cancer	4.03e-06	3.47e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—SRC—lung cancer	4.03e-06	3.47e-05	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—EGFR—lung cancer	4.03e-06	3.47e-05	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—POMC—lung cancer	4.02e-06	3.46e-05	CbGpPWpGaD
Methadone—CYP2C18—Metabolism—PIK3CA—lung cancer	4.01e-06	3.45e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—CYP2A6—lung cancer	4.01e-06	3.45e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—GCLC—lung cancer	4.01e-06	3.45e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—TYMS—lung cancer	4e-06	3.44e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—CYP1A1—lung cancer	3.97e-06	3.42e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—TYMS—lung cancer	3.96e-06	3.41e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—GSTM1—lung cancer	3.95e-06	3.4e-05	CbGpPWpGaD
Methadone—OPRM1—GPCR downstream signaling—AKT1—lung cancer	3.95e-06	3.4e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—ERCC2—lung cancer	3.94e-06	3.39e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—STK11—lung cancer	3.94e-06	3.39e-05	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—POMC—lung cancer	3.93e-06	3.38e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—VEGFA—lung cancer	3.93e-06	3.38e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—GSTM1—lung cancer	3.92e-06	3.37e-05	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—APOA1—lung cancer	3.91e-06	3.37e-05	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—CREBBP—lung cancer	3.91e-06	3.37e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—CASP3—lung cancer	3.91e-06	3.37e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—IL2—lung cancer	3.9e-06	3.36e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—STAT3—lung cancer	3.89e-06	3.35e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling by GPCR—IL6—lung cancer	3.89e-06	3.35e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—NRAS—lung cancer	3.88e-06	3.34e-05	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—CREBBP—lung cancer	3.83e-06	3.29e-05	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—KRAS—lung cancer	3.81e-06	3.28e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—CCND1—lung cancer	3.81e-06	3.28e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—ENO1—lung cancer	3.8e-06	3.27e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—JUN—lung cancer	3.8e-06	3.27e-05	CbGpPWpGaD
Methadone—CYP3A7—Metabolism—PTEN—lung cancer	3.78e-06	3.25e-05	CbGpPWpGaD
Methadone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	3.75e-06	3.23e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—CYP1A1—lung cancer	3.75e-06	3.23e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—ERCC2—lung cancer	3.71e-06	3.2e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—MAPK3—lung cancer	3.71e-06	3.2e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—CYP1A1—lung cancer	3.71e-06	3.2e-05	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—PIK3CD—lung cancer	3.71e-06	3.2e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—MMP9—lung cancer	3.7e-06	3.18e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—lung cancer	3.69e-06	3.18e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—ERCC2—lung cancer	3.68e-06	3.17e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—CDKN1A—lung cancer	3.68e-06	3.17e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—PTEN—lung cancer	3.67e-06	3.16e-05	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—ALB—lung cancer	3.66e-06	3.15e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—GSTP1—lung cancer	3.64e-06	3.14e-05	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—PIK3CD—lung cancer	3.63e-06	3.12e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—MYC—lung cancer	3.61e-06	3.11e-05	CbGpPWpGaD
Methadone—CYP3A7—Metabolism—EP300—lung cancer	3.6e-06	3.1e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling by GPCR—AKT1—lung cancer	3.58e-06	3.09e-05	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—ALB—lung cancer	3.58e-06	3.08e-05	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—PIK3CG—lung cancer	3.57e-06	3.08e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—CAT—lung cancer	3.54e-06	3.05e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—EGFR—lung cancer	3.53e-06	3.04e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism of lipids and lipoproteins—EP300—lung cancer	3.52e-06	3.03e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—EP300—lung cancer	3.5e-06	3.02e-05	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—PIK3CA—lung cancer	3.5e-06	3.01e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—APOA1—lung cancer	3.49e-06	3.01e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—ABCB1—lung cancer	3.45e-06	2.97e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—APOA1—lung cancer	3.41e-06	2.94e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—CYP2E1—lung cancer	3.41e-06	2.94e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—SRC—lung cancer	3.41e-06	2.93e-05	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—POMC—lung cancer	3.4e-06	2.93e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—TYMS—lung cancer	3.39e-06	2.92e-05	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—TP53—lung cancer	3.38e-06	2.91e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—NQO1—lung cancer	3.37e-06	2.9e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—GSTM1—lung cancer	3.35e-06	2.88e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	3.35e-06	2.88e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—KRAS—lung cancer	3.34e-06	2.87e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—VEGFA—lung cancer	3.32e-06	2.86e-05	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—CREBBP—lung cancer	3.31e-06	2.85e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—STAT3—lung cancer	3.29e-06	2.83e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—NRAS—lung cancer	3.28e-06	2.82e-05	CbGpPWpGaD
Methadone—CYP2C18—Metabolism—AKT1—lung cancer	3.28e-06	2.82e-05	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—HRAS—lung cancer	3.24e-06	2.79e-05	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—PIK3CB—lung cancer	3.23e-06	2.79e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—APOA1—lung cancer	3.21e-06	2.77e-05	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—PTGS2—lung cancer	3.2e-06	2.76e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—PIK3CG—lung cancer	3.19e-06	2.75e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—APOA1—lung cancer	3.19e-06	2.74e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—CYP1A1—lung cancer	3.17e-06	2.73e-05	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—PIK3CB—lung cancer	3.16e-06	2.72e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—ERCC2—lung cancer	3.15e-06	2.71e-05	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—PIK3CD—lung cancer	3.14e-06	2.71e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—MAPK3—lung cancer	3.14e-06	2.7e-05	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—PTGS2—lung cancer	3.13e-06	2.7e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—PIK3CG—lung cancer	3.11e-06	2.68e-05	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—ALB—lung cancer	3.1e-06	2.67e-05	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—IL6—lung cancer	3.1e-06	2.67e-05	CbGpPWpGaD
Methadone—CYP19A1—Metabolism—PIK3CA—lung cancer	3.07e-06	2.64e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—PIK3CA—lung cancer	3.07e-06	2.64e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—MYC—lung cancer	3.05e-06	2.63e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	3.05e-06	2.63e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—STK11—lung cancer	3.04e-06	2.62e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—POMC—lung cancer	3.04e-06	2.61e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—EGFR—lung cancer	2.99e-06	2.57e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—TP53—lung cancer	2.97e-06	2.55e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—POMC—lung cancer	2.96e-06	2.55e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—CREBBP—lung cancer	2.96e-06	2.55e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—PIK3CG—lung cancer	2.93e-06	2.53e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—PIK3CG—lung cancer	2.91e-06	2.5e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—CREBBP—lung cancer	2.89e-06	2.49e-05	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—AKT1—lung cancer	2.86e-06	2.46e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—HRAS—lung cancer	2.84e-06	2.44e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—KRAS—lung cancer	2.82e-06	2.43e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—GSTP1—lung cancer	2.81e-06	2.42e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—PIK3CD—lung cancer	2.8e-06	2.41e-05	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—PTEN—lung cancer	2.79e-06	2.41e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—POMC—lung cancer	2.79e-06	2.4e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—POMC—lung cancer	2.77e-06	2.38e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—ALB—lung cancer	2.77e-06	2.38e-05	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—PIK3CB—lung cancer	2.74e-06	2.36e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—PIK3CD—lung cancer	2.74e-06	2.36e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—CAT—lung cancer	2.74e-06	2.36e-05	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—PTEN—lung cancer	2.73e-06	2.35e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—APOA1—lung cancer	2.72e-06	2.34e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—CREBBP—lung cancer	2.72e-06	2.34e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—IL6—lung cancer	2.72e-06	2.34e-05	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—PTGS2—lung cancer	2.71e-06	2.34e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—ALB—lung cancer	2.7e-06	2.33e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—CREBBP—lung cancer	2.7e-06	2.32e-05	CbGpPWpGaD
Methadone—CYP3A7—Metabolism—PIK3CA—lung cancer	2.67e-06	2.3e-05	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—EP300—lung cancer	2.67e-06	2.3e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—ABCB1—lung cancer	2.66e-06	2.29e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—TYMS—lung cancer	2.61e-06	2.25e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	2.61e-06	2.24e-05	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—EP300—lung cancer	2.61e-06	2.24e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—PIK3CA—lung cancer	2.59e-06	2.23e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—GSTM1—lung cancer	2.58e-06	2.22e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—PIK3CD—lung cancer	2.58e-06	2.22e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—PIK3CD—lung cancer	2.56e-06	2.2e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—ALB—lung cancer	2.55e-06	2.19e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—ALB—lung cancer	2.52e-06	2.17e-05	CbGpPWpGaD
Methadone—CYP19A1—Metabolism—AKT1—lung cancer	2.51e-06	2.16e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—TP53—lung cancer	2.51e-06	2.16e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—AKT1—lung cancer	2.51e-06	2.16e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—PIK3CG—lung cancer	2.49e-06	2.14e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—CYP1A1—lung cancer	2.45e-06	2.11e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—PIK3CB—lung cancer	2.44e-06	2.1e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—ERCC2—lung cancer	2.43e-06	2.09e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—PTGS2—lung cancer	2.42e-06	2.09e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—HRAS—lung cancer	2.4e-06	2.07e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—PIK3CB—lung cancer	2.39e-06	2.05e-05	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—PTEN—lung cancer	2.37e-06	2.04e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—POMC—lung cancer	2.37e-06	2.04e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—PTGS2—lung cancer	2.36e-06	2.04e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—CREBBP—lung cancer	2.3e-06	1.98e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—IL6—lung cancer	2.3e-06	1.98e-05	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—EP300—lung cancer	2.26e-06	1.94e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—PIK3CB—lung cancer	2.25e-06	1.94e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—PIK3CB—lung cancer	2.23e-06	1.92e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—PTGS2—lung cancer	2.23e-06	1.92e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—PTGS2—lung cancer	2.21e-06	1.9e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—PIK3CD—lung cancer	2.18e-06	1.88e-05	CbGpPWpGaD
Methadone—CYP3A7—Metabolism—AKT1—lung cancer	2.18e-06	1.88e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—ALB—lung cancer	2.16e-06	1.86e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—AKT1—lung cancer	2.12e-06	1.82e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—PTEN—lung cancer	2.11e-06	1.82e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—APOA1—lung cancer	2.1e-06	1.81e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—PTEN—lung cancer	2.06e-06	1.78e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—EP300—lung cancer	2.01e-06	1.73e-05	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—PIK3CA—lung cancer	1.97e-06	1.7e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—EP300—lung cancer	1.97e-06	1.69e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—PTEN—lung cancer	1.94e-06	1.67e-05	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—PIK3CA—lung cancer	1.93e-06	1.66e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—PTEN—lung cancer	1.93e-06	1.66e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—PIK3CG—lung cancer	1.92e-06	1.65e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—PIK3CB—lung cancer	1.9e-06	1.64e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—PTGS2—lung cancer	1.89e-06	1.62e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—EP300—lung cancer	1.85e-06	1.6e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—EP300—lung cancer	1.84e-06	1.58e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—POMC—lung cancer	1.83e-06	1.57e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—CREBBP—lung cancer	1.78e-06	1.53e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—PIK3CD—lung cancer	1.69e-06	1.45e-05	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—PIK3CA—lung cancer	1.67e-06	1.44e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—ALB—lung cancer	1.66e-06	1.43e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—PTEN—lung cancer	1.65e-06	1.42e-05	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—AKT1—lung cancer	1.61e-06	1.39e-05	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—AKT1—lung cancer	1.57e-06	1.36e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—EP300—lung cancer	1.57e-06	1.35e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—PIK3CA—lung cancer	1.49e-06	1.28e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—PIK3CB—lung cancer	1.47e-06	1.27e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—PTGS2—lung cancer	1.46e-06	1.25e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—PIK3CA—lung cancer	1.45e-06	1.25e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—PIK3CA—lung cancer	1.37e-06	1.18e-05	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—AKT1—lung cancer	1.36e-06	1.17e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—PIK3CA—lung cancer	1.36e-06	1.17e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—PTEN—lung cancer	1.27e-06	1.09e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—AKT1—lung cancer	1.22e-06	1.05e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—EP300—lung cancer	1.21e-06	1.04e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—AKT1—lung cancer	1.19e-06	1.02e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—PIK3CA—lung cancer	1.16e-06	1e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—AKT1—lung cancer	1.12e-06	9.64e-06	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—AKT1—lung cancer	1.11e-06	9.56e-06	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—AKT1—lung cancer	9.48e-07	8.17e-06	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—PIK3CA—lung cancer	8.96e-07	7.72e-06	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—AKT1—lung cancer	7.32e-07	6.3e-06	CbGpPWpGaD
